CLINICAL_TRIALS
trial_result
· 2017-01-04
Clinical Trial Update: Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram [Phase 4]
Summary
Phase 4 study evaluating brain energy metabolism in adults with major depressive disorder treated with escitalopram; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2017-01-04